271 related articles for article (PubMed ID: 16868034)
1. Fibroblast growth factor-2 mediates Angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium.
Donnini S; Solito R; Giachetti A; Granger HJ; Ziche M; Morbidelli L
J Pharmacol Exp Ther; 2006 Nov; 319(2):515-22. PubMed ID: 16868034
[TBL] [Abstract][Full Text] [Related]
2. Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk.
Donnini S; Terzuoli E; Ziche M; Morbidelli L
J Pharmacol Exp Ther; 2010 Mar; 332(3):776-84. PubMed ID: 19959747
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway.
Finetti F; Donnini S; Giachetti A; Morbidelli L; Ziche M
Circ Res; 2009 Sep; 105(7):657-66. PubMed ID: 19713533
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
Gao L; Yu DM
Chin Med J (Engl); 2008 Nov; 121(21):2129-33. PubMed ID: 19080171
[TBL] [Abstract][Full Text] [Related]
5. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
6. Nanostructured HA crystals up-regulate FGF-2 expression and activity in microvascular endothelium promoting angiogenesis.
Pezzatini S; Morbidelli L; Solito R; Paccagnini E; Boanini E; Bigi A; Ziche M
Bone; 2007 Oct; 41(4):523-34. PubMed ID: 17681892
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the cardiac angiogenic response to surgical FGF-2 therapy in a Swine endothelial dysfunction model.
Ruel M; Wu GF; Khan TA; Voisine P; Bianchi C; Li J; Li J; Laham RJ; Sellke FW
Circulation; 2003 Sep; 108 Suppl 1():II335-40. PubMed ID: 12970256
[TBL] [Abstract][Full Text] [Related]
8. Effects of L-arginine on fibroblast growth factor 2-induced angiogenesis in a model of endothelial dysfunction.
Voisine P; Li J; Bianchi C; Khan TA; Ruel M; Xu SH; Feng J; Rosinberg A; Malik T; Nakai Y; Sellke FW
Circulation; 2005 Aug; 112(9 Suppl):I202-7. PubMed ID: 16159817
[TBL] [Abstract][Full Text] [Related]
9. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
Mehta VB; Zhou Y; Radulescu A; Besner GE
Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin AT1 receptor upregulates expression of basic fibroblast growth factor, basic fibroblast growth factor receptor and coreceptor in human coronary smooth muscle cells.
Skaletz-Rorowski A; Pinkernell K; Sindermann JR; Schriever C; Müller JG; Eschert H; Breithardt G
Basic Res Cardiol; 2004 Jul; 99(4):272-8. PubMed ID: 15221345
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of fibroblast growth factor-2 by visfatin that promotes endothelial angiogenesis.
Bae YH; Bae MK; Kim SR; Lee JH; Wee HJ; Bae SK
Biochem Biophys Res Commun; 2009 Feb; 379(2):206-11. PubMed ID: 19100714
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin down-regulates, whereas arginine analogs up-regulates, endothelial nitric-oxide synthase expression in coronary endothelial cells.
Vaziri ND; Ding Y; Ni Z; Barton CH
J Pharmacol Exp Ther; 2005 Apr; 313(1):121-6. PubMed ID: 15640399
[TBL] [Abstract][Full Text] [Related]
14. Adrenomedullin stimulates angiogenic response in cultured human vascular endothelial cells: involvement of the vascular endothelial growth factor receptor 2.
Guidolin D; Albertin G; Spinazzi R; Sorato E; Mascarin A; Cavallo D; Antonello M; Ribatti D
Peptides; 2008 Nov; 29(11):2013-23. PubMed ID: 18692535
[TBL] [Abstract][Full Text] [Related]
15. The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis.
Monti M; Terzuoli E; Ziche M; Morbidelli L
Pharmacol Res; 2013 Oct; 76():171-81. PubMed ID: 23965518
[TBL] [Abstract][Full Text] [Related]
16. B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects.
Morbidelli L; Parenti A; Giovannelli L; Granger HJ; Ledda F; Ziche M
Br J Pharmacol; 1998 Jul; 124(6):1286-92. PubMed ID: 9720802
[TBL] [Abstract][Full Text] [Related]
17. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane.
Lazarovici P; Gazit A; Staniszewska I; Marcinkiewicz C; Lelkes PI
Endothelium; 2006; 13(1):51-9. PubMed ID: 16885067
[TBL] [Abstract][Full Text] [Related]
18. Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice.
Ebrahimian TG; Tamarat R; Clergue M; Duriez M; Levy BI; Silvestre JS
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):65-70. PubMed ID: 15528473
[TBL] [Abstract][Full Text] [Related]
19. Alternatively spliced FGFR-1 isoforms differentially modulate endothelial cell activation of c-YES.
Zhang P; Greendorfer JS; Jiao J; Kelpke SC; Thompson JA
Arch Biochem Biophys; 2006 Jun; 450(1):50-62. PubMed ID: 16631103
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor signaling pathway in endothelial cells is activated by BMPER to promote angiogenesis.
Esser JS; Rahner S; Deckler M; Bode C; Patterson C; Moser M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):358-67. PubMed ID: 25503991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
